dolutegravir 5 MG Tablet for Oral Suspension

RxCUI: 2374562
RxNorm name: dolutegravir 5 MG Tablet for Oral Suspension
Display name: dolutegravir 5 MG Tablet for Oral Suspension
Full name: dolutegravir 5 MG Tablet for Oral Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tivicay	DOLUTEGRAVIR SODIUM	ViiV Healthcare Company	63df5af3-b8ac-4e76-9830-2dbb340af922	2026-08-25	Warnings, Adverse reactions	Exact identifier rxcui: 2374562

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
63df5af3-b8ac-4e76-9830-2dbb340af922	dolutegravir 5 MG Tablet for Oral Suspension [PSN] · dolutegravir 5 MG Tablet for Oral Suspension [SCD] · dolutegravir 5 MG (as dolutegravir sodium) Tablet for Oral Suspension [SY]	3	31	These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013	20251029